Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2020

View Archived Issues

Amgen studies AMG-256 for advanced solid tumors in phase I trial

Following neonatal lead enables spinal cord repair in mice

T-cell 'repliclones' can thwart HIV drugs

Fat-free mice have bigger bones

Test tube HIV enables replication insights

Jiangsu Provincial Center for Disease Control and Prevention patents anti-coronavirus MAbs

Kinnate Biopharma discovers c-RAF inhibitors

Topline phase III results show noninferiority of OPC-61815 versus tolvaptan tablets

Exciting toxicity study implicates TRPM4 in NMDA-mediated cell death

Interim data from FIDES-02 study of derazantinib in advanced urothelial cancer

Fujitsu and PeptiDream announce milestone under joint research effort

Additional interim data presented for WP-1066 in adult glioblastoma

Direct AMPK activator opposes mitochondrial dysfunction, oxidative stress and inflammation in DPN

New STING agonists identified at Lupin

Sumitomo Dainippon Pharma Oncology presents new PKM2 activators

Shanghai Ringene Biopharma synthesizes new BRD and/or c-Myc inhibitors

AnaptysBio reports topline data from phase II GALLOP study of imsidolimab in GPP

First patient dosed in phase I study of NBTXR-3 in pancreatic cancer

Gossamer Bio presents topline phase II data for GB-001

Targeting Ire1-alpha may reduce cystic fibrosis airway inflammation

CARB-X award supports development of Polyphor antibiotic program

New phase I trial evaluates liposomal hydroxychloroquine TLC-19 for COVID-19

Derazantinib active in intrahepatic cholangiocarcinoma with FGFR2 mutations/amplifications

Allob shows 90% fusion rate at 24 months in phase IIa study in lumbar spinal fusion

FDA grants expanded access to ExoFlo for COVID-19-associated ARDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...